NCT02826356View on ClinicalTrials.gov

Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
ACE-I and ARB-induced Angioedema.
Trial Locations (1)

69003

Hospices Civils de Lyon, Département d'Anesthésie-Réanimation, Hôpital Edouard Herriot, Lyon, France., Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02826356 - Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema | Biotech Hunter | Biotech Hunter